BIS Crosses Critical Technical Indicator

In trading on Thursday, shares of the Proshares UltraShort Nasdaq Biotechnology ETF (BIS) entered into oversold territory, changing hands as low as $20.581 per share. We define oversold territory using the Relative Strength Index, or RSI, which is a technical analysis indicator used to measure momentum on a scale of zero to 100. A stock is considered to be oversold if the RSI reading falls below 30.

In the case of Proshares UltraShort Nasdaq Biotechnology, the RSI reading has hit 29.8 — by comparison, the RSI reading for the S&P 500 is currently 70.4.

START SLIDESHOW:
Find out what 9 other oversold stocks you need to know about »

A bullish investor could look at BIS's 29.8 reading as a sign that the recent heavy selling is in the process of exhausting itself, and begin to look for entry point opportunities on the buy side.

Looking at a chart of one year performance (below), BIS's low point in its 52 week range is $20.581 per share, with $69.00 as the 52 week high point — that compares with a last trade of $20.58. Proshares UltraShort Nasdaq Biotechnology shares are currently trading off about 2.3% on the day.

Proshares UltraShort Nasdaq Biotechnology 1 Year Performance Chart

More from Stocks

3 Must Know Market Insights From TheStreet's Jim Cramer Before Wednesday's Open

3 Must Know Market Insights From TheStreet's Jim Cramer Before Wednesday's Open

Short Disney Stock Here: Doug Kass Insider

Short Disney Stock Here: Doug Kass Insider

CHART: Even Consumer Staples Stocks Are Being Pummeled in Tuesday's Market Rout

CHART: Even Consumer Staples Stocks Are Being Pummeled in Tuesday's Market Rout

Why Google, Facebook and Other Tech Giants' Capital Spending Is Going Sky High

Why Google, Facebook and Other Tech Giants' Capital Spending Is Going Sky High

Three Big Factors That Rocked the Stock Market Tuesday

Three Big Factors That Rocked the Stock Market Tuesday